What is the recommended adenosine dose for a pediatric patient based on body weight?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Adenosine Dosing for Pediatric Patients

For pediatric supraventricular tachycardia (SVT), administer adenosine 0.1 mg/kg IV/IO as the initial dose (maximum 6 mg), followed by a rapid flush; if unsuccessful, give a second dose of 0.2 mg/kg (maximum 12 mg). 1

Initial Dose Strategy

The 2025 American Heart Association/American Academy of Pediatrics guidelines provide clear weight-based dosing 1:

  • First dose: 0.1 mg/kg rapid IV/IO push (maximum 6 mg)
  • Second dose: 0.2 mg/kg rapid IV/IO push (maximum 12 mg) if first dose fails
  • Critical technique: Follow each dose immediately with a rapid saline flush

Evidence Supporting Higher Initial Dosing

While guidelines recommend starting at 0.1 mg/kg, the evidence strongly suggests this initial dose is insufficient for most children. Recent systematic review data from 2026 demonstrates that cardioversion success rates increase substantially with higher doses 2:

  • <100 µg/kg (0.1 mg/kg): Only 25% conversion rate
  • 100 µg/kg: 38% conversion rate
  • 150-225 µg/kg: 47% conversion rate
  • 250-400 µg/kg: 59% conversion rate

Multiple observational studies confirm that the median effective dose is actually 200 µg/kg (0.2 mg/kg), with only 36-38% of patients responding to the guideline-recommended 100 µg/kg initial dose 3, 4. This means approximately two-thirds of children will require escalation to higher doses.

Special Populations Requiring Higher Doses

Children with pre-excitation syndromes (Wolff-Parkinson-White) require significantly higher adenosine doses (mean 220 µg/kg vs. 177 µg/kg in those without pre-excitation, p=0.039) 4. If pre-excitation is suspected or documented, anticipate needing the higher 0.2 mg/kg dose or even escalation to 0.3 mg/kg.

Practical Dosing Algorithm

  1. Confirm SVT diagnosis (narrow complex, HR >220/min in infants or >180/min in children, absent/abnormal P waves)
  2. Establish IV/IO access and prepare rapid flush
  3. First dose: 0.1 mg/kg (max 6 mg) rapid push + immediate flush
  4. Wait 1-2 minutes for effect
  5. If unsuccessful, second dose: 0.2 mg/kg (max 12 mg) rapid push + immediate flush
  6. If still unsuccessful: Consider synchronized cardioversion (0.5-1 J/kg) or expert consultation before additional adenosine 1

Critical Safety Considerations

  • Have resuscitation equipment immediately available - rare but serious complications include prolonged asystole, complete AV block, atrial fibrillation, and bronchospasm 5
  • Contraindications: Second/third-degree AV block, sick sinus syndrome, asthma/bronchospastic disease, known hypersensitivity 6
  • Monitor continuously during and for 2 minutes after administration
  • Early recurrence occurs in 25% of cases - this is not a failure of adenosine but reflects the underlying arrhythmia mechanism 7

Common Pitfalls to Avoid

  • Slow administration: Adenosine has a half-life <2 seconds; slow pushes allow metabolism before reaching the heart
  • Inadequate flush: Without immediate vigorous flush, adenosine may not reach central circulation in effective concentration
  • Giving up too early: Most children require 2-3 doses for successful conversion 3
  • Using peripheral IV too far from central circulation: Inject as proximally as possible

The discrepancy between guideline recommendations (starting at 0.1 mg/kg) and real-world effectiveness data (median effective dose 0.2 mg/kg) reflects conservative initial dosing for safety, but clinicians should be prepared to rapidly escalate to the second dose in most patients 2, 3, 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.